Annotation Detail for AMPD1

Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| PWY-6353 | purine nucleotides degradation II (aerobic) |
| Pathway ID | Pathway Name |
|---|
| Metabolism of nucleotides |
| Desease ID | Desease Name |
|---|
| 1781 | Rheumatoid arthritis |
| 1787 | Heart disease |
| 1878 | Ischemia |
| 2075 | Heart failure |
| 2236 | Cardiovascular disease |
| Desease Name |
|---|
| rheumatoid arthritis |
| CARDIOVASCULAR |
| Coronary Artery Disease |
| cardiac function |
| PHARMACOGENOMIC |
| metabolic syndrome |
| METABOLIC |
| insulin |
| left ventricular dysfunction |
| Heart Failure |
| congestive heart failure |
| Desease Name |
|---|
| Myoadenylate deaminase deficiency |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of AMPD1 mRNA | affects expression | 16483693
|
| D005419 |
Flavonoids |
Flavonoids results in increased expression of AMPD1 mRNA | increases expression | 18035473
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.44 | 18287403 |
| MESH:C538234 |
Adenosine monophosphate deaminase deficiency |
marker/mechanism |
|
| |
| MESH:D007249 |
Inflammation |
|
Flavonoids |
2.86 | 17296493 |
| MESH:D018908 |
Muscle Weakness |
marker/mechanism |
|
| 10996775 |
| MESH:D009133 |
Muscular Atrophy |
marker/mechanism |
|
| 10996775 |
| Drugbank ID |
Action |
Drug Name |
Description |
|---|
| DB00131 |
- |
Adenosine monophosphate |
Dietary supplement;Micronutrient |